Insights from 2024 ESGO Annual Meeting


 

ESGO 2024 Insights: "COPELIA Trial - Cediranib With Weekly Paclitaxel or Olaparib vs. Weekly Paclitaxel Chemo for Advanced/Recurrent Endometrial Cancer"

125 views
March 22, 2024
Comments 0
Login to view comments. Click here to Login